Difficulty: Medium
Average Score: 62%
Practice
Probucol (Lorelco) reduces the risk of atherosclerosis by stimulating the rate of clearance of LDL by receptor-mediated pathways. This consideration is:
Correct answer
B
Rationale
In this question, the correct answer is B) FALSE. Probucol (Lorelco) actually reduces the risk of atherosclerosis by inhibiting the oxidation of LDL cholesterol rather than by stimulating the rate of clearance through receptor-mediated pathways.
The incorrect options can be explained as follows:
A) TRUE - This option is incorrect because, as mentioned earlier, Probucol works by inhibiting LDL oxidation, not by stimulating its clearance via receptor-mediated pathways.
C) All of the above - This option is incorrect as it implies that both the statement in the question and its opposite are correct, which is not the case.
D) None of the above - This option is also incorrect because the statement in the question is false.
From an educational perspective, understanding the mechanisms of action of pharmacological agents is crucial for healthcare professionals to make informed decisions regarding patient care. In this case, knowing that Probucol acts by inhibiting LDL oxidation helps healthcare providers understand how it reduces the risk of atherosclerosis. This knowledge can guide appropriate prescribing practices and patient education efforts to optimize therapeutic outcomes.
The incorrect options can be explained as follows:
A) TRUE - This option is incorrect because, as mentioned earlier, Probucol works by inhibiting LDL oxidation, not by stimulating its clearance via receptor-mediated pathways.
C) All of the above - This option is incorrect as it implies that both the statement in the question and its opposite are correct, which is not the case.
D) None of the above - This option is also incorrect because the statement in the question is false.
From an educational perspective, understanding the mechanisms of action of pharmacological agents is crucial for healthcare professionals to make informed decisions regarding patient care. In this case, knowing that Probucol acts by inhibiting LDL oxidation helps healthcare providers understand how it reduces the risk of atherosclerosis. This knowledge can guide appropriate prescribing practices and patient education efforts to optimize therapeutic outcomes.